Docosahexaenoic Acid Modulates Nonalcoholic Fatty Liver Disease by Suppressing Endocannabinoid System
Molecular Nutrition & Food Research · 2024
DOI: 10.1002/mnfr.202300616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Yan-Fang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nutrition & Health, Qingdao University, Qingdao, 266071, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, 2018 Chinese Nutrition Society (CNS), BMSG Research Fund.
Abstract (Originalsprache)
Scope Endocannabinoid signaling regulates energy homeostasis, and is tightly associated with nonalcoholic fatty liver disease (NAFLD). The study previously finds that supplementation of docosahexaenoic acid (DHA) has superior function to ameliorate NAFLD compared with eicosapentaenoic acid (EPA), however, the underlying mechanism remains elusive. The present study aims to investigate whether DHA intervention alleviates NAFLD via endocannabinoid system. Methods and results In a case–control study, the serum endocannabinoid ligands in 60 NAFLD and 60 healthy subjects are measured. Meanwhile, NAFLD model is established in mice fed a high‐fat and ‐cholesterol diet (HFD) for 9 weeks. DHA or EPA is administrated for additional 9 weeks. Serum primary endocannabinoid ligands, namely anandamide (AEA) and 2‐arachidoniylglycerol (2‐AG), are significantly higher in individuals with NAFLD compared with healthy controls. NAFLD model shows that serum 2‐AG concentrations and adipocyte cannabinoid receptor 1 expression levels are significantly lower in DHA group compared with HFD group. Lipidomic and targeted ceramide analyses further confirm that endocannabinoid signaling inhibition has exerted deletion of hepatic C16:0‐ceramide contents, resulting in down‐regulation of de novo fatty acid synthesis and up‐regulation of fatty acid β‐oxidation related protein expression levels. Conclusions This work elucidates that DHA has improved NAFLD by suppressing endocannabinoid system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Nutrition & Health, Qingdao University, Qingdao, 266071, China.
- School of Public Health, Qingdao University, Qingdao, 266071, China.
- Qingdao University Function Center of Medical Nutrition, Qingdao, 266071, China.
ORCID-Profile: Xiao-Fei Guo
Förderung
- National Natural Science Foundation of China
- 2018 Chinese Nutrition Society (CNS)
- BMSG Research Fund
Zitieren
APA
Chen, Y. F., Fan, Z. K., Wang, Y. P., Liu, P., Guo, X. F., & Li, D. (2024). Docosahexaenoic Acid Modulates Nonalcoholic Fatty Liver Disease by Suppressing Endocannabinoid System. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300616
Vancouver
Chen YF, Fan ZK, Wang YP, Liu P, Guo XF, Li D. Docosahexaenoic Acid Modulates Nonalcoholic Fatty Liver Disease by Suppressing Endocannabinoid System. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202300616
BibTeX
@article{Chen2024,
author = {Chen, Yan-Fang and Fan, Ze-Kai and Wang, Yin-Peng and Liu, Peng and Guo, Xiao-Fei and Li, Duo},
title = {Docosahexaenoic Acid Modulates Nonalcoholic Fatty Liver Disease by Suppressing Endocannabinoid System},
journal = {Molecular Nutrition & Food Research},
year = {2024},
doi = {10.1002/mnfr.202300616}
}
EUVIMED